ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ERGO Ergomed Plc

1,346.00
0.00 (0.00%)
10 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ergomed Plc LSE:ERGO London Ordinary Share GB00BN7ZCY67 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,346.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ergomed Share Discussion Threads

Showing 326 to 348 of 1050 messages
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older
DateSubjectAuthorDiscuss
07/10/2019
08:50
steady buying this morning
mfhmfh
27/9/2019
09:44
great company... share price back to 330p soon. IMHO.
mfhmfh
27/9/2019
07:09
Ergomed PLC reports strong order book and significant new business wins
piedro
25/9/2019
11:32
Plenty of board changes
Hopefully all for the best

Interims:
- Revenue £35.2m (up 36.8%)
- Adjusted EBITDA £6.5m vs £0.0m in H1 2018
- Backlog £118.3m (up 26.9%)
repeated ad infinitum
Is that due to the nature of the profession, data medical data ...
or something else?

piedro
23/8/2019
12:29
Cherio from the States

We see another new 52 Wk high? Anything driving this that you guys are aware of?

Please read about the Ergo/CVM connection here:

ih_198062
23/8/2019
11:36
Dr. Eghosa Olaolu Imasogie joins PrimeVigilance as Chief Medical Officer
PUBLISHED 22 AUGUST 2019.

piedro
23/8/2019
11:20
I never bought this stock or indeed PRSM when I should have done...ffs
mirabeau
23/8/2019
11:15
solid buys coming in today
mfhmfh
13/8/2019
15:14
Courtesy of sushifishman, Cel-Sci published an updated fact sheet on 9th August which shows that they are still waiting for 298 events (deaths) in their ongoing Multikine phase III trial.

The head & neck cancer trial completed recruitment with its 928th patient in September 2016 and is continuing to monitor survival. The trial will end when 298 events have occurred and that was expected to happen in 2018 so the fact that they haven't yet reached that threshold may be promising.

bermudashorts
27/7/2019
09:19
Of course we don’t actually know that Fullbrook Thorpe are retaining their remaining shares as they are now below the 3% level so they don’t have to report any further sales. I was wondering where all these shares recently on the market were coming from and now we know (at least in part). But clearly the three new recruitments are a VERY impressive list of people and Barfield’s interview was excellent. I suspect that a sizeable fundraising will happen shortly as they seek a war chest for acquisitions. Barfield was a bit cagey about acquisitions, which made me believe that they are very much on the agenda. I’m extremely bullish.
ih_433513
27/7/2019
08:58
jamtomorrow,

Yes, you're correct re. Fullbrook Thorpe, original TR1 is below. They crossed the notification threshold in May 2016 but didn't notify until November 2016. They would have bought at around 140p so a pretty good return. It's not at all surprising to see some profit taking from institutions and reassuring to see them retaining large positions.

bermudashorts
27/7/2019
08:41
Think same applied to Gresham House's TR1 - haven't gone back to check but think it was a reduction rather than a new position. Have taken my eye off the ball with Ergomed so not 100% sure of previous major holdings but seem to remember Gresham House having a position.
bermudashorts
27/7/2019
07:39
I’ve just seen this

hxxps://www.marketscreener.com/ERGOMED-PLC-16917574/company/

Fullbrook Thorpe used to own 3.17% of Ergomed so this announcement is a reduction in their holding. They clearly don’t know how to complete these TR-1 forms properly!

ih_433513
27/7/2019
07:19
Maybe there’s the connection. Peter George was CEO of Clinigen and he is a director of Ergomed. Perhaps George and Leaver are acting in concert. Peter George holds 1.74% of Ergomed so if they are in concert they own more than 3% hence the announcement.
ih_433513
27/7/2019
07:04
>>>>Jamtomorrow

Don't know for sure, but the main man behind Fuller Thorpe Investments is Andrew Leaver, founder of Clinigen (where he still retains 3%)

timbo003
26/7/2019
20:59
Why did Fullbrook Thorpe declare their holding when it’s less than 3%? Perhaps they are in concert with someone else or connected with a director, neither of which was declared. Interesting though.
ih_433513
26/7/2019
17:09
Another larger investment in Ergo. . Fullbrook Thorpe Investments LLP adds 1.2M shares.

hxxp://www.share-talk.co.uk/announcements/rns/ergomed-plc/holding-s-in-company/201907261530059212G

ih_198062
26/7/2019
07:23
Piedro, lol sorry, forgot that ADVFN automatically deletes proactive links.

mfhmfh - thanks

bermudashorts
25/7/2019
16:17
B.Shorts - a link please
piedro
25/7/2019
12:51
Impressive interview with new CFO Richard Barfield

[...]

bermudashorts
23/7/2019
15:07
North Atlantic Smaller Companies Investment Trust PLC adds another 600K per the RNS just filed
ih_198062
22/7/2019
14:32
really big buys
mfhmfh
22/7/2019
13:23
Big buys coming in now
epicsurf
Chat Pages: Latest  18  17  16  15  14  13  12  11  10  9  8  7  Older

Your Recent History

Delayed Upgrade Clock